Use of Cyanobacterium Spirulina Associated with Amitraz to Treatment in Juvenile Generalized Canine Demodiciosis

作者:Bezerra Leandro Ferreira; de Souza Almir Pereira; de Melo Marcia Almeida; Wanderlei Layse de Lucena; Mendes Rodrigo de Souza*
来源:Acta Scientiae Veterinariae, 2013, 41: 1124.

摘要

Background: The canine demodicosis (CD) is a parasitic skin disease of inflammatory, non-contagious, caused by excessive proliferation in hair follicles and sebaceous glands of a specific skin mite, Demodex canis. It is often seen in purebred dogs and short hair, and there was no gender bias. It is multifactorial, however, the juvenile form arises due to immunosuppression of cellular immunity and a hereditary predisposition, one of the most common skin disease in the veterinary clinic, especially in tropical and subtropical regions, where it tends to follow a more aggressive course. The cyanobacterium Spirulina is an aquatic microorganism that contains a huge amount of essential nutrients and bioavailable to the body, widely used in the world because of its nutritional richness and character immunostimulant, revealed in research. Thus, the aim of this research was to evaluate the effectiveness of adding the cyanobacterium Spirulina in the treatment of young dogs suffering from generalized demodicosis.
Material, Methods & Results: We used ten dogs with canine demodiciosis widespread youth, confirmed by the distributive pattern of injuries and the parasitologic cutaneos scraping (EPRC). The animals were divided into two experimental groups denominated GS (group spirulina) and CG (control group) of equal number (n = 5), where the first (GS) received daily oral spirulina and baths weekly with amitraz for 90 days. For the animals of GC was adopted the same protocol for GS, but without the addition of spirulina. Hematologic evaluations were performed and serum biochemistry in three stages, the first before the application of design (M0) and the other every 45 days (M1 and M2). The animals were submitted to clinical and parasite every 15 days, the cure parasitic determined by obtaining three negative EPRC at intervals of 15 days between them. After discharge, the animals were followed for one year for any finding of recurrence. The dogs of the GS group (100%) had complete remission of clinical signs in an average of 52 days and parasitological cure obtained at 70 +/- 5 days, with no history of relapses over a year. In the control group dogs had only three parasitologic cure within described in method (80 +/- 5 days) while healing was clinically observed in 80% of the dogs at an average time of 64 days. As regards the hematology indices were observed changes in the hematocrit (Ht) CG and VCM (mean corpuscular volume) in both groups. In total leukocyte count was observed a demonstration of leukocytosis in isolade M0/GS. There was no change on the biochemical variables studied.
Discussion: From the data obtained can be seen that the group that received Spirulina (GS) showed a high clinical and parasitological recovery (EPRC) earlier and more effective (52 days and 70 +/- 5 days), respectively, when compared to dogs in the control group (GC). However, no observation of persistence of low hematimetric GS group, as well as the rapid recovery clinical and parasitological may have been determined by the addition of spirulina therapy control on the DCG juvenile animals studied, since it has large amount of nutrients available to the organism itself and its immunostimulating properties. However, it is necessary to adopt more organic indicators for reasons of greater benefits, especially as regards the immunological entities. Thus we can conclude that spirulina determined earlier recovery of affected patients DCG youth, and there was no any change clinical undesirable organic and commitment resulting from its chemical composition, revealing benefits as adjuvant therapy for the treatment of canine demodiciosis.

  • 出版日期2013-5-28